메뉴 건너뛰기




Volumn 21, Issue 24, 2015, Pages 7427-7435

Liver fibrosis markers of nonalcoholic steatohepatitis

Author keywords

Glycated albumin; Glycated hemoglobin; Liver fibrosis; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLYCOSYLATED ALBUMIN; GLYCOSYLATED PROTEIN; HEMOGLOBIN A1C; HYALURONIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRIACYLGLYCEROL;

EID: 84936818548     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i24.7427     Document Type: Article
Times cited : (63)

References (74)
  • 1
    • 84888730523 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease and nutrition
    • Dooley JS, Lok AS, Burroughs AK, Heathcote EJ, editors, 12th ed. Oxford: Blackwell Sci Pub
    • Caldwell SH, Argo CK. Non-alcoholic fatty liver disease and nutrition. In: Dooley JS, Lok AS, Burroughs AK, Heathcote EJ, editors. Sherlock's Diseases of the liver and biliary system. 12th ed. Oxford: Blackwell Sci Pub, 2011:546-567
    • (2011) Sherlock's Diseases of the Liver and Biliary System , pp. 546-567
    • Caldwell, S.H.1    Argo, C.K.2
  • 2
    • 0029165057 scopus 로고
    • Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver
    • 7475591
    • Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995;346:987-990 [PMID: 7475591 DOI: 10.1016/S0140-6736 (95) 91685-7]
    • (1995) Lancet , vol.346 , pp. 987-990
    • Teli, M.R.1    Day, C.P.2    Burt, A.D.3    Bennett, M.K.4    James, O.F.5
  • 4
    • 78651041767 scopus 로고
    • The liver in obesity
    • 14943295
    • Zelman S. The liver in obesity. AMA Arch Intern Med 1952;90:141-156 [PMID: 14943295]
    • (1952) AMA Arch Intern Med , vol.90 , pp. 141-156
    • Zelman, S.1
  • 5
    • 0019152816 scopus 로고
    • Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
    • 7382552
    • Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-438 [PMID: 7382552]
    • (1980) Mayo Clin Proc , vol.55 , pp. 434-438
    • Ludwig, J.1    Viggiano, T.R.2    McGill, D.B.3    Oh, B.J.4
  • 6
    • 0022568321 scopus 로고
    • Nonalcoholic fatty liver disease
    • 3086934
    • Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis 1986;8:283-298 [PMID: 3086934]
    • (1986) Prog Liver Dis , vol.8 , pp. 283-298
    • Schaffner, F.1    Thaler, H.2
  • 7
    • 84861543083 scopus 로고    scopus 로고
    • The diagnosis and management of nonalcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    • 22488764
    • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-2023 [PMID: 22488764]
    • (2012) Hepatology , vol.55 , pp. 2005-2023
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3    Diehl, A.M.4    Brunt, E.M.5    Cusi, K.6    Charlton, M.7    Sanyal, A.J.8
  • 9
    • 77952529040 scopus 로고    scopus 로고
    • A position statement on NAFLD/NASH based on the EASL 2009 special conference
    • 20494470
    • Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372-384 [PMID: 20494470]
    • (2010) J Hepatol , vol.53 , pp. 372-384
    • Ratziu, V.1    Bellentani, S.2    Cortez-Pinto, H.3    Day, C.4    Marchesini, G.5
  • 12
    • 0345017740 scopus 로고    scopus 로고
    • Sampling variability of liver fibrosis in chronic hepatitis C
    • 14647056
    • Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457 [PMID: 14647056 DOI: 10.1016/j.hep. 2003.09.022]
    • (2003) Hepatology , vol.38 , pp. 1449-1457
    • Bedossa, P.1    Dargère, D.2    Paradis, V.3
  • 15
    • 33847202224 scopus 로고    scopus 로고
    • Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis
    • 17312065
    • Friedrich-Rust M, Ong MF, Herrmann E, Dries V, Samaras P, Zeuzem S, Sarrazin C. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 2007;188:758-764 [PMID: 17312065 DOI: 10.2214/AJR.06.0322]
    • (2007) AJR Am J Roentgenol , vol.188 , pp. 758-764
    • Friedrich-Rust, M.1    Ong, M.F.2    Herrmann, E.3    Dries, V.4    Samaras, P.5    Zeuzem, S.6    Sarrazin, C.7
  • 17
    • 79951473084 scopus 로고    scopus 로고
    • Acoustic Radiation Force Impulse (ARFI) - A new modality for the evaluation of liver fibrosis
    • 21165451
    • Sporea I, Sirli R, Popescu A, Danilã M. Acoustic Radiation Force Impulse (ARFI) - a new modality for the evaluation of liver fibrosis. Med Ultrason 2010;12:26-31 [PMID: 21165451]
    • (2010) Med Ultrason , vol.12 , pp. 26-31
    • Sporea, I.1    Sirli, R.2    Popescu, A.3    Danilã, M.4
  • 18
    • 78751476826 scopus 로고    scopus 로고
    • Noninvasive assessment of liver fibrosis
    • 21254180
    • Martínez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology 2011;53:325-335 [PMID: 21254180 DOI: 10.1002/hep. 24013]
    • (2011) Hepatology , vol.53 , pp. 325-335
    • Martínez, S.M.1    Crespo, G.2    Navasa, M.3    Forns, X.4
  • 19
    • 84898548864 scopus 로고    scopus 로고
    • Current status of fibrosis markers
    • 24671009
    • Patel K, Shackel NA. Current status of fibrosis markers. Curr Opin Gastroenterol 2014;30:253-259 [PMID: 24671009 DOI: 10.1097/MOG.0000000000000059]
    • (2014) Curr Opin Gastroenterol , vol.30 , pp. 253-259
    • Patel, K.1    Shackel, N.A.2
  • 20
    • 84917737431 scopus 로고    scopus 로고
    • Non-invasive diagnosis of advanced fibrosis and cirrhosis
    • 25492996
    • Sharma S, Khalili K, Nguyen GC. Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol 2014;20:16820-16830 [PMID: 25492996]
    • (2014) World J Gastroenterol , vol.20 , pp. 16820-16830
    • Sharma, S.1    Khalili, K.2    Nguyen, G.C.3
  • 21
    • 0029000625 scopus 로고
    • Serum hyaluronan as a marker of liver fibrosis
    • 7665843
    • Guéchot J, Poupon RE, Poupon R. Serum hyaluronan as a marker of liver fibrosis. J Hepatol 1995;22:103-106 [PMID: 7665843]
    • (1995) J Hepatol , vol.22 , pp. 103-106
    • Guéchot, J.1    Poupon, R.E.2    Poupon, R.3
  • 22
    • 0026267725 scopus 로고
    • Hepatic fibrosis and its serum markers: A review
    • 1752069
    • Gabrielli GB, Corrocher R. Hepatic fibrosis and its serum markers: a review. Dig Dis 1991;9:303-316 [PMID: 1752069]
    • (1991) Dig Dis , vol.9 , pp. 303-316
    • Gabrielli, G.B.1    Corrocher, R.2
  • 23
    • 33845602180 scopus 로고    scopus 로고
    • Evaluation of platelet kinetics in patients with liver cirrhosis: Similarity to idiopathic thrombocytopenic purpura
    • 17201890
    • Kajihara M, Okazaki Y, Kato S, Ishii H, Kawakami Y, Ikeda Y, Kuwana M. Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol 2007;22:112-118 [PMID: 17201890]
    • (2007) J Gastroenterol Hepatol , vol.22 , pp. 112-118
    • Kajihara, M.1    Okazaki, Y.2    Kato, S.3    Ishii, H.4    Kawakami, Y.5    Ikeda, Y.6    Kuwana, M.7
  • 24
    • 0036829982 scopus 로고    scopus 로고
    • Noninvasive monitoring of patients with chronic hepatitis C
    • 12407577
    • Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002;36:S57-S64 [PMID: 12407577]
    • (2002) Hepatology , vol.36 , pp. S57-S64
    • Fontana, R.J.1    Lok, A.S.2
  • 25
  • 26
    • 0035820265 scopus 로고    scopus 로고
    • Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study
    • 11297957
    • Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-1075 [PMID: 11297957 DOI: 10.1016/S0140-6736 (00) 04258-6]
    • (2001) Lancet , vol.357 , pp. 1069-1075
    • Imbert-Bismut, F.1    Ratziu, V.2    Pieroni, L.3    Charlotte, F.4    Benhamou, Y.5    Poynard, T.6
  • 28
    • 0042265556 scopus 로고    scopus 로고
    • A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
    • 12883497
    • Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526 [PMID: 12883497 DOI: 10.1053/jhep. 2003.50346]
    • (2003) Hepatology , vol.38 , pp. 518-526
    • Wai, C.T.1    Greenson, J.K.2    Fontana, R.J.3    Kalbfleisch, J.D.4    Marrero, J.A.5    Conjeevaram, H.S.6    Lok, A.S.7
  • 33
    • 33847705375 scopus 로고    scopus 로고
    • FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C
    • 17256741
    • Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007;45:297-306 [PMID: 17256741]
    • (2007) Hepatology , vol.45 , pp. 297-306
    • Koda, M.1    Matunaga, Y.2    Kawakami, M.3    Kishimoto, Y.4    Suou, T.5    Murawaki, Y.6
  • 35
    • 9644272496 scopus 로고    scopus 로고
    • Evaluation of a panel of noninvasive serum markers to differentiate mild from moderate-toadvanced liver fibrosis in chronic hepatitis C patients
    • 15582126
    • Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, Pawlotsky JM, McHutchison JG. Evaluation of a panel of noninvasive serum markers to differentiate mild from moderate-toadvanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004;41:935-942 [PMID: 15582126]
    • (2004) J Hepatol , vol.41 , pp. 935-942
    • Patel, K.1    Gordon, S.C.2    Jacobson, I.3    Hézode, C.4    Oh, E.5    Smith, K.M.6    Pawlotsky, J.M.7    McHutchison, J.G.8
  • 36
    • 0037129380 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease
    • 11961152
    • Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231 [PMID: 11961152]
    • (2002) N Engl J Med , vol.346 , pp. 1221-1231
    • Angulo, P.1
  • 37
    • 22844448952 scopus 로고    scopus 로고
    • Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease
    • 15998429
    • Suzuki A, Angulo P, Lymp J, Li D, Satomura S, Lindor K. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int 2005;25:779-786 [PMID: 15998429 DOI: 10.1111/j.1478-3231.2005.01064.x]
    • (2005) Liver Int , vol.25 , pp. 779-786
    • Suzuki, A.1    Angulo, P.2    Lymp, J.3    Li, D.4    Satomura, S.5    Lindor, K.6
  • 41
    • 79960979728 scopus 로고    scopus 로고
    • APRI: A simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH
    • 21920102
    • Kruger FC, Daniels CR, Kidd M, Swart G, Brundyn K, van Rensburg C, Kotze M. APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH. S Afr Med J 2011;101:477-480 [PMID: 21920102]
    • (2011) S Afr Med J , vol.101 , pp. 477-480
    • Kruger, F.C.1    Daniels, C.R.2    Kidd, M.3    Swart, G.4    Brundyn, K.5    Van Rensburg, C.6    Kotze, M.7
  • 42
    • 84909619421 scopus 로고    scopus 로고
    • Noninvasive biomarkers in nonalcoholic fatty liver disease: Current status and a glimpse of the future
    • 25152587
    • Fitzpatrick E, Dhawan A. Noninvasive biomarkers in nonalcoholic fatty liver disease: current status and a glimpse of the future. World J Gastroenterol 2014;20:10851-10863 [PMID: 25152587 DOI: 10.3748/wjg.v20.i31.10851]
    • (2014) World J Gastroenterol , vol.20 , pp. 10851-10863
    • Fitzpatrick, E.1    Dhawan, A.2
  • 43
    • 70349546276 scopus 로고    scopus 로고
    • Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease
    • 19523535
    • Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7:1104-1112 [PMID: 19523535 DOI: 10.1016/j.cgh.2009.05.033]
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 1104-1112
    • Shah, A.G.1    Lydecker, A.2    Murray, K.3    Tetri, B.N.4    Contos, M.J.5    Sanyal, A.J.6
  • 46
    • 0032695030 scopus 로고    scopus 로고
    • Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
    • 10573511
    • Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-1362 [PMID: 10573511]
    • (1999) Hepatology , vol.30 , pp. 1356-1362
    • Angulo, P.1    Keach, J.C.2    Batts, K.P.3    Lindor, K.D.4
  • 47
    • 0034950652 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
    • 11438497
    • Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100 [PMID: 11438497]
    • (2001) Gastroenterology , vol.121 , pp. 91-100
    • Dixon, J.B.1    Bhathal, P.S.2    O'Brien, P.E.3
  • 50
    • 80555136061 scopus 로고    scopus 로고
    • Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
    • 21039302
    • Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617-649 [PMID: 21039302]
    • (2011) Ann Med , vol.43 , pp. 617-649
    • Musso, G.1    Gambino, R.2    Cassader, M.3    Pagano, G.4
  • 51
    • 52649112178 scopus 로고    scopus 로고
    • Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
    • 18390575
    • Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008;57:1441-1447 [PMID: 18390575 DOI: 10.1136/gut.2007.146019]
    • (2008) Gut , vol.57 , pp. 1441-1447
    • Harrison, S.A.1    Oliver, D.2    Arnold, H.L.3    Gogia, S.4    Neuschwander-Tetri, B.A.5
  • 55
    • 1942454310 scopus 로고    scopus 로고
    • Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics
    • 15152612
    • Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 2004;10:429-434 [PMID: 15152612]
    • (2004) Nat Med , vol.10 , pp. 429-434
    • Callewaert, N.1    Van Vlierberghe, H.2    Van Hecke, A.3    Laroy, W.4    Delanghe, J.5    Contreras, R.6
  • 56
    • 67449106681 scopus 로고    scopus 로고
    • GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics
    • 19181623
    • Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics 2009;8:986-994 [PMID: 19181623 DOI: 10.1074/mcp. M800470-MCP200]
    • (2009) Mol Cell Proteomics , vol.8 , pp. 986-994
    • Vanderschaeghe, D.1    Laroy, W.2    Sablon, E.3    Halfon, P.4    Van Hecke, A.5    Delanghe, J.6    Callewaert, N.7
  • 58
  • 61
    • 0027519943 scopus 로고
    • Protein glycosylation. Structural and functional aspects
    • 8243456
    • Lis H, Sharon N. Protein glycosylation. Structural and functional aspects. Eur J Biochem 1993;218:1-27 [PMID: 8243456]
    • (1993) Eur J Biochem , vol.218 , pp. 1-27
    • Lis, H.1    Sharon, N.2
  • 62
    • 84862645392 scopus 로고    scopus 로고
    • Glycation research in amino acids: A place to call home
    • 20981459
    • Rabbani N, Thornalley PJ. Glycation research in amino acids: a place to call home. Amino Acids 2012;42:1087-1096 [PMID: 20981459 DOI: 10.1007/s00726-010-0782-1]
    • (2012) Amino Acids , vol.42 , pp. 1087-1096
    • Rabbani, N.1    Thornalley, P.J.2
  • 64
    • 0017835519 scopus 로고
    • The glycosylation of hemoglobin: Relevance to diabetes mellitus
    • 635569
    • Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978;200:21-27 [PMID: 635569]
    • (1978) Science , vol.200 , pp. 21-27
    • Bunn, H.F.1    Gabbay, K.H.2    Gallop, P.M.3
  • 65
    • 0028988142 scopus 로고
    • Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level
    • 7497851
    • Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995;18:440-447 [PMID: 7497851]
    • (1995) Diabetes Care , vol.18 , pp. 440-447
    • Tahara, Y.1    Shima, K.2
  • 66
    • 0018742880 scopus 로고
    • Glycosylation of serum albumin: Elevated glycosyl-albumin in diabetic patients
    • 467671
    • Dolhofer R, Wieland OH. Glycosylation of serum albumin: elevated glycosyl-albumin in diabetic patients. FEBS Lett 1979;103:282-286 [PMID: 467671]
    • (1979) FEBS Lett , vol.103 , pp. 282-286
    • Dolhofer, R.1    Wieland, O.H.2
  • 67
    • 0018648409 scopus 로고
    • Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus
    • 291961
    • Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 1979;76:4258-4261 [PMID: 291961]
    • (1979) Proc Natl Acad Sci USA , vol.76 , pp. 4258-4261
    • Guthrow, C.E.1    Morris, M.A.2    Day, J.F.3    Thorpe, S.R.4    Baynes, J.W.5
  • 68
    • 84897898535 scopus 로고    scopus 로고
    • Glycated albumin; clinical usefulness
    • 24631132
    • Koga M. Glycated albumin; clinical usefulness. Clin Chim Acta 2014;433:96-104 [PMID: 24631132 DOI: 10.1016/j.cca.2014.03.001]
    • (2014) Clin Chim Acta , vol.433 , pp. 96-104
    • Koga, M.1
  • 69
    • 47649129223 scopus 로고    scopus 로고
    • CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases
    • 18513821
    • Koga M, Kasayama S, Kanehara H, Bando Y. CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract 2008;81:258-262 [PMID: 18513821 DOI: 10.1016/j.diabres.2008.04.012]
    • (2008) Diabetes Res Clin Pract , vol.81 , pp. 258-262
    • Koga, M.1    Kasayama, S.2    Kanehara, H.3    Bando, Y.4
  • 70
    • 69749114550 scopus 로고    scopus 로고
    • Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease
    • 19675058
    • Bando Y, Kanehara H, Toya D, Tanaka N, Kasayama S, Koga M. Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem 2009;46:368-372 [PMID: 19675058 DOI: 10.1258/acb.2009.008231]
    • (2009) Ann Clin Biochem , vol.46 , pp. 368-372
    • Bando, Y.1    Kanehara, H.2    Toya, D.3    Tanaka, N.4    Kasayama, S.5    Koga, M.6
  • 74
    • 84885166200 scopus 로고    scopus 로고
    • Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
    • 24252302
    • Pearce SG, Thosani NC, Pan JJ. Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. Biomark Res 2013;1:7 [PMID: 24252302 DOI: 10.1186/2050-7771-1-7]
    • (2013) Biomark Res , vol.1 , pp. 7
    • Pearce, S.G.1    Thosani, N.C.2    Pan, J.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.